Οn the 13th of October this year, the Ministry of Health in Ukraine presented for public discussion the Cabinet of Ministers’ draft legislation named “ Some Issues Concerning The Licensing of Commercial Activity”, the text of which has been published on the Ministry’s official website.
The draft legislation proposes to vest upon the State Administration on Medicinal Products and the State Administration on Drug Control the authority to license commercial activities, which they possessed before the entry into force of the Cabinet of Ministers decree № 609 , dating from 05.08.2015 “ Concerning the recognition of the list of authorities, whose licensing and recognition lost the validity of certain decrees by the Cabinet of Ministers of Ukraine”, before the completion of the transfer of licensing acts to the reorganized State Administration on Medicinal Products and the State Administration on Drug Control.
In particular, according to the draft legislation
It should be reminded that on the 26th August 2015, on the entry into force of the Cabinet of Ministers’ decree № 609 “Concerning the recognition of the list of authorities, whose licensing and recognition lost the validity of certain decrees by the Cabinet of Ministers of Ukraine” the authority of the State Administration on Medicinal Products and the State Administration on Drugs Control as licensing organs of the above mentioned commercial activities was terminated. Instead, the State Authority on Medicinal Products and Drug Control was determined as the new licensing organ, which up until now has not commenced its’ functioning.
Thus, it was determined that a currently nonexistent state organ, is de facto, administering the licensing of the above mentioned commercial activities.
Precisely with the aim of regulating the situation at hand, namely, the prevention of the termination of the licensing procedures of the abovementioned commercial activities, the adoption of the draft legislation , which “continues” the authority, as licensing organs, of the State Administration on Medicinal Products and the State Administration on Drug Control, which are reorganizing until the completion of the transfer of licensing acts to the State Administration of medicinal products and drug control.
We are thrilled to announce a major milestone in our team's growth and celebrate the well-deserved career advancements of our colleagues.
Lexology Index: Employment & Labor highlights the leading legal specialists in the field from around the world.
On June 19, 2026, an event was held with the participation of businesses, regulators, and experts – titled “Regulatory Dialogue: The Cosmetics Market” – organiz
The event brought together leading industry experts for a comprehensive analysis of the institutional landscape and current legal challenges in the sphere of state-business interaction.